Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Bradford T Whitmore is Director at Ultralife. OQRO lists 22 transactions filed with the SEC under this name, the latest on May 26, 2026, each linked to the official Form 4.
Director
Disclosures on record
22
Companies involved
2
Bradford T Whitmore bought shares on the open market in 15 different years since 2008 across 2 companies. Sales in 6 of the 19 years since 2008.
Bradford T Whitmore reported 464 open-market purchases and 9 sales since 2008; purchases in 15 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $1.91M6×6 trades | — |
| 2025 | $29.3M14×14 trades | $28.1M2×2 trades |
| 2024 | $1.53M4×4 trades | — |
| 2023 | $1.47M33×33 trades | — |
| 2022 | $2.25M23×23 trades | — |
| 2021 | $32.9M5×5 trades | $32.4M1×1 trade |
| 2020 | $1.2M13×13 trades | — |
| 2019 | $1.68M1×1 trade | — |
| 2017 | $1.32M10×10 trades | — |
| 2016 | $1.63M55×55 trades | — |
| 2013 | — | $87K2×2 trades |
| 2012 | $1.33M9×9 trades | $1.24M2×2 trades |
| 2011 | $18.2M33×33 trades | $18M1×1 trade |
| 2010 | $631K1×1 trade | $631K1×1 trade |
| 2009 | $2.51M72×72 trades | — |
| 2008 | $2.06M185×185 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
9 buys, median −17.0 pts vs S&P 500, beat it 3 of 9 times.
Average −10.0 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed May 15, 2025 to May 26, 2026, measured from the first close after the filing. Past results, not a forecast.
9 purchases disclosed; 33% of the 9 measured at 90 days finished ahead of the index. $1,000 placed after each of the 4 purchases disclosed since 2025-11-16 would be worth $9.8K today ($4K put in); the same in the S&P 500 (SPY): $4.4K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
UltralifeULBI
18 disclosures · May 2025 – May 2026 · 18 bought
May 26, 2026Bought~$459K
DetailsOfficial recordMay 21, 2026Bought~$202Kdisclosed May 26
DetailsOfficial recordMay 22, 2026Bought~$55Kdisclosed May 26
DetailsOfficial recordMar 13, 2026Bought~$636Kdisclosed Mar 16
DetailsOfficial recordMar 16, 2026Bought~$359K
DetailsOfficial recordMar 12, 2026Bought~$201Kdisclosed Mar 16
DetailsOfficial recordDec 16, 2025Bought~$163K
DetailsOfficial recordDec 15, 2025Bought~$84Kdisclosed Dec 16
DetailsOfficial recordDec 12, 2025Bought~$54Kdisclosed Dec 16
DetailsOfficial recordNov 19, 2025Bought~$268Kdisclosed Nov 21
DetailsOfficial recordAug 21, 2025Bought~$197K
DetailsOfficial recordAug 19, 2025Bought~$104Kdisclosed Aug 21
DetailsOfficial recordAug 20, 2025Bought~$85Kdisclosed Aug 21
DetailsOfficial recordJun 13, 2025Bought~$76K
DetailsOfficial recordMay 23, 2025Bought~$65Kdisclosed May 28
DetailsOfficial recordMay 14, 2025Bought~$88Kdisclosed May 15
DetailsOfficial recordMay 13, 2025Bought~$48Kdisclosed May 15
DetailsOfficial recordMay 15, 2025Bought~$12K
DetailsOfficial recordSolesenceSLSN
4 disclosures · Jun 2025 · 2 bought · 2 sold
May 29, 2025Bought~$17.6Mdisclosed Jun 2
DetailsOfficial recordMay 29, 2025Bought~$10.5Mdisclosed Jun 2
DetailsOfficial recordMay 29, 2025Sold~$17.6Mdisclosed Jun 2
DetailsOfficial recordMay 29, 2025Sold~$10.5Mdisclosed Jun 2
DetailsOfficial recordAs of the latest filing on , Bradford T Whitmore reported holding 49,043,149 shares of Solesence (SLSN), worth about $82.9M at the last close of $2 (Nov 17, 2026), held through a whitmore holdings, llc, a strandler, llc. Holdings are also on file at Ultralife (ULBI); together they are worth about $115M. In the last 12 months, Bradford T Whitmore bought $2.48M in 10 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Solesence SLSN | 49,043,149 | 18.7M whitmore holdings, llc · 30.4M strandler, llc | $2 | $82.9M | May 29, 2025 |
| Ultralife ULBI | 2,050,637 | 2.05M whitmore holdings, llc | $16 | $32.1M | May 26, 2026 |
Is this Bradford T Whitmore’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Bradford T Whitmore reported 281 open-market purchases and 8 sales here, 2008 to 2025.
Bradford T Whitmore reported 183 open-market purchases and 1 sale here, 2009 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated May 29, 2025, Bradford T Whitmore reported holding 49,043,149 shares of Solesence (SLSN), held indirectly. At the last close of $2 on Nov 17, 2026, that is about $82.9M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Bradford T Whitmore reported 10 open-market purchases worth $2.48M, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Bradford T Whitmore bought shares on the open market in 15 different years since 2008 across 2 companies. Sales in 6 of the 19 years since 2008.
In SEC filings since 2008: the latest open-market purchase is from 2026; the latest open-market sale is from 2025.
2 companies: Ultralife (ULBI, 2009–2026), Solesence (SLSN, 2008–2025).